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A B S T R A C T
Diabetes has been increasing at an alarming rate around the world, and experts have relied
on remedies from the utilization of ancient drugs that are essentially derived from plants.
The present study aimed to evaluate the antidiabetic potential of Chloroxylon swietenia bark
extracts on streptozotocin induced diabetic rats. Diabetes was induced in male albinoWistar
rats by single intraperitoneal injection of streptozotocin (STZ) (50 mg/kg b.w.). The diabetic
rats were administered orally with C. swietenia bark (CSB) methanolic (CSBMEt) and aqueous
(CSBAEt) (250 mg/kg b.w.) extracts and glibenclamide (600 μg/kg b.w.) by intragastric intu-
bation for 45 days. The result showed a heavy loss in weight, increase in blood glucose and
glycosylated hemoglobin level, and decline in plasma insulin and total hemoglobin content.
Furthermore, glucose-6-phosphatase and fructose-1,6-bis phosphatase were found to be in-
creased whereas hexokinase and glycogen contents were decreased in STZ induced diabetic
rats. CSBAEt, CSBMEt and glibenclamide treated diabetic rats showed moderate reduction
in blood glucose and glycosylated hemoglobin levels; in addition, plasma insulin and he-
moglobin levels were elevated.The altered activities of carbohydrate metabolizing enzymes
and liver glycogen were improved remarkably. CSBMEt results were comparable to the stan-
dard drug glibenclamide. The present findings support the usage of the plant extracts for
the traditional treatment of diabetes.
© 2016 Beni-Suef University. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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1. Introduction
Diabetes mellitus (DM) could be a bunch of metabolic disor-
ders portrayed via hyperglycemia following imperfections in
insulin emission, insulin activity, or both. The chronic hyper-
glycemia is identified with stretched pathology and damage,
which distress multiple organs. It additionally incorporates a
bigger chance of getting dyslipidemia, high blood pressure, and
obesity (American Diabetes Association, 2011). The pathogen-
esis of insulin-dependent DM includes ecological reasons that
may initiate immune system mechanisms on hereditarily de-
fenseless people, prompting dynamic loss of pancreatic islet
β-cell resulting in insulin deficiency (Harrison and Honeyman,
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1999; Gurudeeban et al., 2012). Non-insulin-dependent DM is
related to impaired insulin secretion, obesity, insulin resis-
tance, and hereditary disposition in individuals over 40 years
of age (Zimmet et al., 1990). Streptozotocin could be an intense
poison to the islets of Langerhans and causes extreme diabe-
tes (Brenna et al., 2003). This condition is characterized by a
noteworthy increment in serum glucose levels and a huge less-
ening in insulin discharge (Abdelmeguid et al., 2010).The surplus
glucose within blood responds to hemoglobin (Hb) and frame
glycosylated hemoglobin (HbA1c) (Koenig et al., 1976). Prior
reports have demonstrated that insulin boosts property of
glibenclamide and has thereby been accepted as qualified an-
tidiabetic medication (Andrade Cetto et al., 2000).
The therapeutic management of polygenic disorder without
feature impacts remains disputed. In light of the developing
enthusiasm on assessing homegrown cures, these are seen to
be less harmful and to possess insignificant feature impacts
(Gupta et al., 2012). East Indian satinwood grows in dry de-
ciduous forest, and is indigenous to Asian countries. It has been
employed as a part of chimerical medicine (Venkataswam et al.,
2010).This plant is conventionally used for cuts, burns, wounds,
rheumatism, optical infection, snakebites, etc. (Kiran et al., 2008).
Various extracts of Chloroxylon swietenia have been reported to
possess antimicrobial activity (Vinatha and Estari, 2013), an-
tibacterial and antihelminthic (Ranjith et al., 2011)
hepatoprotective, antioxidant (Palani et al., 2010), larvicidal
(Kiran et al., 2006), anti-inflammatory (Kumar et al., 2006), and
analgesic (Senthilraja and Ramkumar, 2003) properties, and root
bark consumed along with milk have been reported to treat
impotence (Parrotta, 2001). Investigation of lipid profile and
ocular oxidative stress of C. swietenia on Streptozotocin-
nicotinamide-induced diabetic rats (Patchimatla et al., 2014)
was studied in aerial parts. However STZ induced animal model
on C. swietenia bark (CSB) extracts was not yet studied. The
current study was intended to explore the antidiabetic activ-
ity of aqueous (CSBAEt) and methanolic extracts (CSBMEt) of
C. swietenia bark (CSB) on STZ induced diabetic rats.
2. Materials and methods
2.1. Chemicals
STZ and glibenclamide was obtained from Sigma-Aldrich
Company (Bangalore, India). The other experimental chemi-
cals used were of analytical grade and were purchased from
HiMedia (Mumbai, India).
2.2. Plant material collection, processing, and preparation
of extracts
CSB placed in rue family was gathered amid December from
Kalvarayan Hills Kallakurichi, Tamil Nadu, India. Dr. V.
Chelladhurai (Research Officer – Botany Central Council for Re-
search in Ayurveda and Siddha, Govt. of India) has given the
taxonomic distinguishing proof. It was shade dried for a month,
granulated in mechanical grinder and stuffed within airproof
pack. CSB (300 g) was extracted with methanol (1 L) by soxhlet
apparatus (72 h), and the mixture was dried (45 °C) in a rotary
evaporator (Heidolph, Germany).The pounded bark (300 g) was
soaked (3 days) in distilled water (1 L) in ambient tempera-
ture, subjected to periodic agitation and set aside using cotton
attachment. Afterward, the bark was taken out with the use
ofWhatman filter paper (no. 1) and dehydrated at ambient tem-
perature. The dried extracts were stored at 4 °C until further
use.
2.3. Experimental animals
Grown-up adult male albinoWistar rats with body weight (b.w.)
above 180 g at 8 to 10 weeks from conception were acquired
from MadhavaramVeterinary Medical College, Chennai, Tamil
Nadu, India. They have been housed at poly propylene con-
fines and kept up in standard environment [12 h light and 12 h
dark cycle, (25 ± 3)°C].The rats were fed with standard rat pellet
diet (Pranav Agro Industry Ltd, Maharashtra) and given water
ad libitum and maintained at Central Animal House, RMMCH.
All studies were conducted as per the National Institute of
Health’s Guide for the Care and Use of Laboratory Animals, and
the study was endorsed by the Institutional Animal Ethical
Committee of Rajah Muthiah Medical College and Hospital (Pro-
posal No. 998, Reg. No. 160/1999/CPCSEA),Annamalai University,
Tamil Nadu, India. Animals were adapted for 3 days in the re-
search laboratory before start of the experiments.
2.4. Experimental induction of diabetes
Diabetes was prompted through single intraperitoneal injec-
tion of freshly prepared streptozotocin (STZ) (50 mg/ kg b.w.)
in 0.1 M citrate buffer (pH = 4.5) to overnight starved rats (Gupta
and Gupta, 2009). Diabetic rats were permitted to drink 20%
glucose solution overnight to overcome the initial drug induced
hypoglycemic death.The blood glucose level wasmeasured after
three days, and rats with glucose levels >250 mg/dL were con-
sidered as diabetic. At the time of induction, control rats were
injected with 0.2mL of vehicle (0.1 M citrate buffer, pH 4.5) alone.
2.5. Experimental design
In this experiment 30 rats (6 normal and 24 STZ diabetic ex-
isting rats) were used.They were separated into five groups of
6 rats each. The CSBMEt were dissolved in 2% CMC (Carboxyl
methyl cellulose) in distilled water (Kumar et al., 2011), CSBAEt
and glibenclamide 0.5 mL of 0.9% saline and administered orally
(45 days).
Group I. Control rats (were given 0.5 mL of 0.9% saline orally
for 45 days).
Group II. Diabetic group (STZ 50 mg/kg b.w.).
Group III. Diabetic rats were given CSBAEt (250 mg/kg b.w.
dissolved in 0.5 mL of 0.9% saline) orally for 45 days.
Group IV. Diabetic rats were given CSBMEt (250 mg/kg b.w.
dissolved in 0.5 mL of CMC) for 45 days.
Group V. Diabetic rats were given Glibenclamide (600 μg/
kg b.w. dissolved in 0.5 mL of 0.9% of saline) for 45 days
(Subash et al., 2007).
Toward the study’s end (45 days), the animals were euthan-
ized by ketamine (24 mg/kg/body) intramuscular injection and
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sacrificed by cervical decapitation between 9:00 and 11:00 am
tominimize diurnal variation.The blood was gathered.The liver
was dissected and washed with ice-cold saline immediately
to remove blood. Fresh/frozen liver (1 g) was slashed and ho-
mogenized in ice-cold sucrose (15 mL, 250 mM) with a Potter-
Elvehjem homogenizer for 2 minutes, centrifuged at 10,000 rpm
for 30 minutes, and the supernatant was gathered and uti-
lized as the source for different biochemical estimation. The
body weight of all the animals was recorded proceeding to the
treatment and sacrifice.
2.6. Biochemical analysis
2.6.1. Estimation of blood glucose
Glucose level in plasma was determined by glucose oxidase/
peroxidase method as described by Trinder (1969) using a
reagent kit. In brief, to 0.01 mL of plasma, standard and dis-
tilled water (blank) into 3 test tubes, 1.0 mL of the enzyme was
added, mixed and kept at 37 °C for 15 minutes. The color de-
veloped was read at 505 nm against reagent blank.
2.6.2. Qualitative determination of plasma insulin
The plasma insulin was assayed by Enzyme Linked
Immunosorbent Assay (ELISA) method using Boehringer-
Mannheim kit (Andersen et al., 1993). In brief, 0.1 mL of plasma
was injected into the plastic tubes coated withmonoclonal anti-
insulin antibodies. Phosphate buffer and anti-insulin POD
conjugate was added to form anti-insulin antibody–POD con-
jugate. Substrate chromogen solution was then added to form
indicators reaction. A set of standards were also treated in a
similar manner. After the development of color the absor-
bance was read at 420 nm.
2.6.3. Determination of hemoglobin
Hemoglobin content in blood was determined by the cyan-
methemoglobin method of Drabkin and Austin (1932). In brief,
the reaction mixture in a volume of 5.02 mL contained 5 mL
of Drabkin’s reagent and 0.02 mL of blood.The reaction mixture
was kept at room temperature for 5 min to ensure the comple-
tion of the reaction.The solution was read at 540 nm together
with the standard solution of cyanmethemoglobin.
2.6.4. Estimation of glycosylated hemoglobin (HbA1c)
HbA1c in the blood was estimated by the method of Nayak and
Pattabiraman (1981). The saline washed erythrocytes (0.5 mL)
were lysed with 5.5 mL of water, mixed and incubated at 37 °C
for 15 minutes. The contents were centrifuged and the super-
natant was discarded, then 0.5 mL of saline was added, mixed
and processed for estimation. To 0.02 mL of aliquot, 4 mL of
oxalate hydrochloric solution was added and mixed.The con-
tents were heated at 100 °C for 4 hours, cooled and precipitated
with 2 mL of 40% TCA. The mixture was centrifuged and to
0.5 mL of supernatant, 0.05 mL of 80% phenol and 3.0 mL of
concentrated H2SO4 were added.The color developed was read
at 480 nm after 30 minutes.
2.6.5. Estimation of liver glycogen
Hepatic glycogen content was estimated by the method of
Morales et al. (1973). A known amount of the tissue was sub-
jected to alkali digestion in a boiling water bath for 20 minutes
after addition of 5 mL of 30% potassium hydroxide. The tubes
were cooled and 3.0 mL of absolute ethanol and a drop of am-
monium acetate were added. The tubes were then placed in
a freezer overnight to precipitate the glycogen. The precipi-
tated glycogen was collected after centrifugation at 3000× g for
10 minutes. The precipitate was washed thrice with alcohol
and dissolved in 3 mL of water. Aliquots were taken and 4 mL
of anthrone reagent was added to the tubes kept in an ice bath,
mixed and heated in a boiling water bath for 20 minutes. The
green color developed was read at 640 nm.Working standard
glucose and a blank were treated similarly.
2.6.6. Assay of hepatic hexokinase (ec2.7.1.1)
Hepatic hexokinase activity was assayed by the method of
Brandstrup et al. (1957).The reaction mixture in a total volume
of 5.3 mL contained the following: 1 mL of glucose solution,
0.5 mL of ATP solution, 0.1 mL of magnesium chloride solu-
tion, 0.4 mL of potassium dihydrogen phosphate, 0.4 mL of
potassium chloride, 0.4 mL of sodium fluoride and 2.5 mL of
Tris–HCl buffer (pH 8.0).The mixture was pre-incubated at 37 °C
for 5 min. The reaction was initiated by the addition of 2 mL
of tissue homogenate. 1 mL of the reaction mixture was im-
mediately transferred to the tubes containing 1 mL of 10%TCA
that was considered as zero time.A second aliquot was removed
after 30 minutes incubation at 37 °C. The protein precipitate
was removed by centrifugation and the residual glucose in the
supernatant was estimated by the method of Trinder (1969).
2.6.7. Activity of hepatic glucose-6-phosphatase (ec 3.1.3.9)
Glucose-6-phosphatase was assayed by the method of Koida
and Oda (1959). Incubation mixture contained 0.7 mL of citrate
buffer, 0.3 mL of substrate, and 0.3 mL of tissue homogenate.
The reaction mixture was incubated at 37 °C for 1 h. Addition
of 1 mL of 10% TCA to the reaction tubes terminated the re-
action of the enzyme.The suspension was centrifuged and the
phosphorus content of the supernatant of tissue homog-
enate was estimated by the method of Fiske and Subbarow
(1925).The supernatant was adjusted to known volume.To this
1 mL of ammonium molybdate was added followed by 0.4 mL
of ANSA (amino napthol sulfonic acid). After 20 min the ab-
sorbance was read at 680 nm.
2.6.8. Assay of fructose-1,6-bisphosphatase activity
(ec3.1.3.11)
Fructose-1, 6-bisphosphatase activity was measured by the
method of Gancedo and Gancedo (1971). The assay mixture in
a final volume of 2 mL contained 1.2 mL ofTris-HCl buffer (0.1M,
pH 7.0), 0.1 mL of substrate (0.05M), 0.25 mL of magnesium chlo-
ride (0.1M), 0.1 mL of potassium chloride (0.1M), 0.25 mL of EDTA
(Ethylene diamine tetra acetic acid) (0.001M) and 0.1 mL of liver
homogenate. The incubation was carried out at 37 °C for 15
minutes. The reaction was terminated by adding 1 mL of 10%
TCA.The suspension was centrifuged and the supernatant was
used for phosphorus determination by the method of Fiske and
Subbarow (1925). The supernatant was adjusted to known
volume.To this 1 mL of ammonium molybdate was added fol-
lowed by 0.4 mL of ANSA.After 20 min the absorbance was read
at 680 nm.
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2.7. Histopathological studies
The liver tissues of the tested rats were fixed in 10% formal-
dehyde, dried out in an evaluated arrangement of ethanol and
embedded in paraffin. Liver sections (5 μm thick) were ac-
quired utilizing rotary microtome, and afterward rehydrated.
Sections were then stained by hematoxylin-eosin (H&E) (Kehar
and Wahi, 1967) and viewed under the light microscope and
shot by photomicrography.
2.8. Statistical analysis
All values were expressed as mean ± SD. The statistical sig-
nificance was evaluated by one-way analysis of variance
(ANOVA) using SPSS and the Duncan’s Multiple Range Test
(DMRT). A value of p < 0.05 was considered to indicate a sig-
nificant difference between groups.
3. Result
Changes in body weight (Fig. 1), blood glucose (15, 30 and 45
days) (Fig. 2), plasma insulin (Fig. 3), Hb (Fig. 4), and HbA1c in
normal and experimental rats are presented (Fig. 5).
A vast reduction in the body weight was seen in STZ
prompted untreated diabetic control rats when compared with
normal rats. Significant increment in the body weight of dia-
betic rats treated with CSBMEt, CSBAEt and glibenclamide were
observed when compared to diabetic control rats. Blood glucose
of the diabetic rats was higher than the normal rats. Signifi-
cant increase in insulin was observed at the end of the
treatment period and decrease in blood glucose level was ob-
served from the 15th day of treatment in diabetic rats treated
with CSBMEt, CSBAEt and glibenclamide. Decreased Hb and in-
creased HbA1C were observed in diabetic control rats, and these
values were improved significantly upon treatment with the
CSBMEt, CSBAEt and glibenclamide on STZ induced diabetic
rats. CSBMEt and glibenclamide treatment results on the dia-
betic rats were comparative.
Fig. 1 – Effect of CSB extracts on body weight in normal and
experimental rats. Values are expressed as Mean ± SD
(n = 6 rats in each group). Statistical significance was
evaluated by one-way analysis of variance (ANOVA) and
the Duncan’s Multiple Range Test (DMRT). bp < 0.05 as
compared with normal ratsa. cp < 0.05 as compared with
diabetic controlb. dp < 0.05 as compared with diabetic
controlb. CSBAEt – Chloroxylon swietenia bark aqueous
extract (250 mg/kg). CSBMEt – C. swietenia bark methanol
extract (250 mg/kg).
Fig. 2 – Effect of CSB extracts on blood glucose level of
normal and experimental rats. Values are expressed as
Mean ± SD (n = 6 rats in each group). Statistical significance
was evaluated by one-way analysis of variance (ANOVA)
and the Duncan’s Multiple Range Test (DMRT). bp < 0.05 as
compared with normal ratsa. cp < 0.05 as compared with
diabetic controlb. dp < 0.05 as compared with diabetic
controlb. CSBAEt – Chloroxylon swietenia bark aqueous
extract (250 mg/kg). CSBMEt – C. swietenia bark methanol
extract (250 mg/kg).
Fig. 3 – Effect of CSB extracts on Plasma Insulin levels in
normal and experimental rats. Values are expressed as
Mean ± SD (n = 6 rats in each group). Statistical significance
was evaluated by one-way analysis of variance (ANOVA)
and the Duncan’s Multiple Range Test (DMRT). bp < 0.05 as
compared with normal ratsa. cp < 0.05 as compared with
diabetic controlb. dp < 0.05 as compared with diabetic
controlb. CSBAEt – Chloroxylon swietenia bark aqueous
extract (250 mg/kg). CSBMEt – C. swietenia bark methanol
extract (250 mg/kg).
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Significant elevation of glucose-6-phosphatase, fructose-
1,6-bisphophatase and declined hexokinase activity was found
in STZ instigated diabetic rats when compared with normal
rats. However, the treated groups had a tendency to convey
these values to normal. Liver glycogen was diminished in STZ
induced diabetic rats. CSBMEt, CSBAEt and glibenclamide sig-
nificantly increased the liver glycogen levels (Table 1) in STZ
induced diabetic rats.
Fig. 6 shows the histopathological consequences of normal
and experimental rat liver. Extensive vacuolization degener-
ated nuclei was observed in STZ induced diabetic rat liver (B)
when compared to normal rats (A), while diabetic rats treated
with CSBAEt (C) and CSBMEt (D) group indicated improved his-
topathology of the liver as compared to the diabetic control
group rats. Glibenclamide (E) treated group rats showed liver
histopathology similar to the normal control rats.
4. Discussion
In this study, STZ (50 mg/kg b.w.) was utilized as diabeto-
genic operator to prompt the diabetes in albino Wistar rats.
Heavy loss in body weight was observed in STZ induced dia-
betic rats. Minimum dosage of STZ was normally utilized to
incite type I diabetes (Sithole, 2009). STZ partly destroys the
beta cells bringing about inadequate insulin discharge, creat-
ing type 2 diabetes (Gomes et al., 2001). It is the generally used
animal model for the diabetic study (Weir et al., 1981). Dimin-
ishing body weight in diabetic rats plainly affirms a corruption
of basic proteins because of diabetes (Rajkumar and
Govindarajulu, 1991).The deficit in body weight noticed in STZ
instigated diabetic control rats may be due to muscle squan-
dering (Swanston-Flatt et al., 1990; Chatterjee and Shinde, 2002).
Oral administration of CSBAEt, CSBMEt and glibenclamide
results in weight gain in STZ induced diabetic rats.
In DM, insulin is not or inadequately incorporated, creat-
ing hyperglycemia, which leads to change in glucose synthesis.
A previous report proposes that to facilitate normal plasma
insulin plays a vital role in keeping up the glucose equilib-
rium through upgrading glycolysis (Shimazu, 1987). Similarly
decreased insulin and increased glucose level were observed
in STZ induced diabetic rats; oral administration of CSBAEt,
CSBMEt and glibenclamide results in recovery of blood glucose
and plasma insulin significantly. Acute toxicity studies re-
vealed the non-toxic nature of CSBMEt and CSBAEt at high
concentrations. CSB extracts had a tendency to lower the blood
glucose level over a period of 15 days’ treatment in STZ induced
diabetic rats (Jayaprasad et al., 2015b). In light of the out-
comes it can now be proposed that hoisted pancreatic insulin
discharge might improve glucose use through fringe tissues
of diabetic rats by upgrading glucose uptake or else via hin-
dering hepatic gluconeogenesis in addition to diminished blood
glucose concentrations (Sundaram et al., 2014; Tanko et al.,
2008). The conceivable component by which extracts inter-
vene in their antidiabetic impacts could be by potentiation of
pancreatic discharge of insulin from existing b-cells of islets,
as shown by the huge increment in the level of insulin in the
extract treated rats (Ramkumar et al., 2011).
HbA1c concentrations are a helpful and solid tool for the
appraisal of glycemic control in diabetics as suggested by the
International Diabetes Federation (Consensus Committee, 2007).
Our study likewise bolsters the past study that HbA1c levels
was hoisted in addition to exhausted total hemoglobin levels
Fig. 4 – Effect of CSB extracts on total hemoglobin level of
normal and experimental rats. Values are expressed as
Mean ± SD (n = 6 rats in each group). Statistical significance
was evaluated by one-way analysis of variance (ANOVA)
and the Duncan’s Multiple Range Test (DMRT). bp < 0.05 as
compared with normal ratsa. cp < 0.05 as compared with
diabetic controlb. dp < 0.05 as compared with diabetic
controlb. ep < 0.05 as compared with diabetic controlb.
CSBAEt – Chloroxylon swietenia bark aqueous extract
(250 mg/kg). CSBMEt – C. swietenia bark methanol extract
(250 mg/kg).
Fig. 5 – Effect of CSB extracts on glycosylated hemoglobin
level on normal and experimental rats. Values are
expressed as Mean ± SD (n = 6 rats in each group).
Statistical significance was evaluated by one-way analysis
of variance (ANOVA) and the Duncan’s Multiple Range Test
(DMRT). bp < 0.05 as compared with normal ratsa. cp < 0.05 as
compared with diabetic controlb. dp < 0.05 as compared with
diabetic controlb. ep < 0.05 as compared with diabetic
controlb. CSBAEt – Chloroxylon swietenia bark aqueous
extract (250 mg/kg). CSBMEt – C. swietenia bark methanol
extract (250 mg/kg).
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in diabetic control rats.Treatment groups (CSBAEt, CSBMEt and
glibenclamide) of diabetic rats unquestionably decrease the level
of HbA1c and increased the total hemoglobin level. This may
be a direct result of the initiation of glycogen production frame-
work of the extract. A noteworthy decrease of HbA1c showed
the ability of the extract in the control of diabetes (Shirwaikar
et al., 2005). Similar results were observed by previous re-
searchers who found that Plectranthus esculenthus restored the
blood glucose, Hb and HbA1c levels in STZ induced diabetic
rats (Eleazu et al., 2014).
Liver plays a critical part in glucose balance in diabetic con-
dition (Nordlie et al., 1999). Diminished glycolysis, hindered
glycogenesis and expanded gluconeogenesis are a progres-
sive part of glucose synthesis in diabetic liver (Baquer et al.,
1998). Hexokinase first enzyme in glycolysis (Tara and Teitell,
2014) joins transformation of glucose to G6P in addition to vi-
tality (Kumar et al., 2014). Decreased movement of hexokinase
prompts weakened oxidation of glucose by means of glycoly-
sis, bringing about diabetic state and diminished adenosine
triphosphate generation (Ramachandran and Saravanan, 2013).
Table 1 – Effect of CSB extracts on carbohydrate metabolic enzymes and liver glycogen of normal and experimental rat
liver.
Parameters Normal Diabetic control CSBAEt CSBMEt Glibenclamide
Hexokinase 4.02 ± 0.03a 1.46 ± 0.05b 3.59 ± 0.05c 3.89 ± 0.07d 3.92 ± 0.01d
Glu-6-phosphatase 7.65 ± 0.05a 18.43 ± 0.07b 9.65 ± 0.04c 8.73 ± 0.04d 8.66 ± 0.04d
Fru-1-6-bis phosphatase 4.87 ± 0.04a 10.35 ± 0.02b 5.16 ± 0.05c 4.48 ± 0.04d 4.89 ± 0.04d
Glycogen 15.89 ± 0.06a 7.99 ± 0.08b 13.66 ± 0.05c 15.32 ± 0.06d 15.65 ± 0.05d
Values are expressed as Mean ± SD for six rats (n = 6 rats in each group).
Glu-6-phosphatase – nmoles of Pi liberated / min/ mg protein; Fru-1-6-bis phosphatase – nmoles of Pi liberated / min/ mg protein; Hexokinase
– nmoles of glucose phosphorylated/min/g protein; Glycogen –mg per gm tissue; Free Fatty Acid –mg per gm in wet tissue.
Statistical significance was evaluated by one-way analysis of variance (ANOVA) and the Duncan’s Multiple Range Test (DMRT).
b p < 0.05 as compared with normal ratsa.
c p < 0.05 as compared with diabetic controlb.
d p < 0.05 as compared with diabetic controlb.
CSBAEt – Chloroxylon swietenia bark aqueous extract (250 mg/kg).
CSBMEt – Chloroxylon swietenia bark methanol extract (250 mg/kg).
Fig. 6 – Histopathology. Figure shows the photomicrographs of H and E staining of liver tissues of control and Experimental
rats. (A) Normal rat liver shows normal hepatocytes. (B) Diabetic rat liver shows disappearance of nuclei with extensive
vacuolization. (C) Diabetic rats treated with CSBAEt show the regeneration of nuclei with minimal vacuolization. (D) CSBMEt
shows the regeneration of nuclei. (E) Diabetic rats treated with glibenclamide significantly attenuated hepatocytes.
66 b en i - s u e f un i v e r s i t y j o u rna l o f b a s i c and a p p l i e d s c i e n c e s 5 ( 2 0 1 6 ) 6 1 – 6 9
Diminished level of insulin in the STZ impelled diabetic animals
at last prompts the impedance in the activity of hexokinase,
since lack of insulin is a sign of diabetes (Postic et al., 2001).
Diminished hexokinase level was found in diabetic rats though;
CSBMEt, CSBAEt and glibenclamide expanded the action of
hexokinase. Results acquired may be due to the increased level
of insulin.
Insulin directs the exercises of carbohydrate metabolic
enzymes and gluconeogenic enzymes such as G6P and F1,6BP
(Prasath and Subramanian, 2011). Enhanced hepatic glucose
production and impaired hepatic glucose utilization in STZ
prompted diabetic rats might be mediated by dysregulation of
hepatic G6P activity (Alemzadeh et al., 2002). In the present
study increased gluconeogenic enzymes were observed in STZ
induced diabetic rats. Hepatic glucose production is in-
creased in a diabetic state and has been found to be directly
associated with the impaired suppression of G6P and F1,6BP.
The activity of G6P is stimulated by cAMP (Schmoll et al., 1999)
and inhibited via insulin (Gardner et al., 1993). Reduced en-
dogenous glucose production may play a central role in
maintaining glucose homeostasis and implicates insulin in the
gluconeogenic flux (Balamurugan et al., 2015). Action of these
gluconeogenic enzyme increments in the liver of diabetic rats
could be due to insulin deficiency (Baquer et al., 1998;
Kavishankar and Lakshmidevi, 2014). Diabetic rats adminis-
tered with CSBMEt, CSBAEt and glibenclamide modified the
levels of G6P and F1,6BP to near normal, which may be due
to higher insulin emission.
Glucose is stored as glycogen in intracellular regions
(Kalaivanan and Pugalendi, 2011) and serves as a tissue reserve
for the body’s glucose needs. The transformation of glucose
to glycogen relies on the existence of insulin; insulin arouses
glycogen synthesis by means of animating glycogen level and
hindering glycogen phosphorylase (Stalmans et al., 1991;
Bhandari et al., 2013). DM disables the typical limit of liver to
incorporate glycogen. Synthase phosphatase incites glyco-
gen synthase achieving glycogenesis (Prabu et al., 2012). In this
study, diabetic rats exhibited a significant reduction in liver gly-
cogen content. Diabetic rats treated with CSBMEt, CSBAET and
glibenclamide appropriated liver glycogen levels to normal.The
activity of glycogen synthase is controlled by diminished cell
glycogen content, hormone signaling, sub-cell limitation, fo-
cusing of phosphatase and allosteric initiation by G6P (Parker
et al., 2004). The flawed glycogen concentration of the dia-
betic condition was in part rectified by the extract (Arokiyaraj
et al., 2011).
Natural antioxidant agents fundamentally originate from
plants in the form of secondary metabolites (Marjorie, 1996).
The presence of different types of phytochemicals like alka-
loids, coumarins, flavonoids and steroids could be responsible
for the antidiabetic activities (Sharma, 2012). Previously we have
reported that CSB extracts (CSBMEt and CSBAEt) possess the
presence of various phyto constituents such as tannins, steroid,
glycosides, phenolic compounds, anthroquinones and flavo-
noids, and especially total phenol and flavonoid contents seem
to be high and both extracts showed their own strong in vitro
free radical scavenging activity (Jayaprasad and Sharavanan,
2015a). CSBMEt and CSBAEt are capable of restoring the tissue
glycoprotein components in STZ induced diabetic rats
(Jayaprasad et al., 2015c). Thus the antidiabetic effect of
C. swietenia bark methanol and aqueous extracts might be due
to these phytochemical constituents.
5. Conclusion
According to our findings, the C. swietenia bark methanol and
aqueous extracts have proved to possess antidiabetic activity
in STZ induced diabetic rats, which might be due to increase
in plasma insulin levels, and this would be responsible for the
restoration of carbohydrate metabolizing enzymes and liver gly-
cogen. Results of CSBMEt are more effective and comparable
to the standard drug glibenclamide. Further research on the
molecular mechanism and the isolation of the compound re-
sponsible for this effect may lead to a new antidiabetogenic
agent.
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